Faraday future announces closing of strategic $41 million investment in qualigen therapeutics (nasdaq: qlgn) to accelerate its dual-flywheel & dual-bridge eco strategy

Qlgn is expected to rebrand as cxc10 soon, reflecting its new strategic direction around crypto and web3 business. los angeles, sept.
FFAI Ratings Summary
FFAI Quant Ranking